Brief: Immutep Announces Completion of the Safety Lead-In and Opening of the Randomized Phase II of the AIPAC-003 Phase II/III Trial in Metastatic Breast Cancer
06/11/2023 14:14
Nov 6 (Reuters) - Immutep Ltd IMM.AX :
* IMMUTEP ANNOUNCES COMPLETION OF THE SAFETY LEAD-IN AND
OPENING
OF THE RANDOMIZED PHASE II OF THE AIPAC-003 PHASE II/III TRIAL
IN METASTATIC BREAST CANCER
* IMMUTEP LTD - GOOD SAFETY PROFILE ALLOWS FOR LEAD-IN PHASE
TO BE
CLOSED EARLY AND RANDOMIZED PHASE II PORTION OF STUDY WILL NOW
PROCEED
Source text for Eikon: ID:nGNX6fj0sH
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))